ANDA 201069, held by Strides Pharma Intl. Sevelamer Carbonate.
As of Nov 16, 2026, ANDA 201069 (Sevelamer Carbonate), held by Strides Pharma Intl, was first approved by FDA on Aug 5, 2020, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 5, 2020 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Sevelamer Carbonate800MG ยท tablet;oral | Sevelamer Carbonate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters